000 05007nam a2200397 c 4500
710 2 _aSpringerLink (Online service)
_9106996
999 _c112468
_d112468
_x1
001 112468
003 ES-MaUEC
005 20230102113529.0
006 a||||fo|||| 00| 0
007 cr nn 008mamaa
008 190522s2019 gw a o |||| 0|eng d
020 _a9783319962443
024 7 _a10.1007/978-3-319-96244-3
_2doi
040 _bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aRC280 .L8
_b2019 EB
245 0 0 _aCaring for Patients with Mesothelioma :
_cedited by Mary Hesdorffer, Gleneara E. Bates-Pappas
_bPrinciples and Guidelines
264 1 _aCham
_bSpringer International Publishing :
_bImprint: Springer
_c2019.
300 _a1 recurso en línea [X, 239 páginas 54 ilustraciones, 46 ilustraciones a color]
336 _2rdacontent
_aTexto
_btxt
337 _2rdamedia
_aelectrónico
_bc
338 _2rdacarrier
_arecurso electrónico
_bcr
347 _atext file
_bPDF
490 0 _aMedicine (Springer-11650)
505 0 _aChapter 1: The history of Mesothelioma and medical research -- Part I: Mesothelioma treatment_Chapter 2: Early history of Peritoneal surgery -- Chapter 3: History of Pleural surgical treatment -- Chapter 4: History of clinical trials -- Chapter 5: Caring for patients undergoing pleural surgery -- Chapter 6: Peritoneal Treatment -- Chapter 7: Radiation Therapy -- Part II: Therapeutic treatments: chemotherapy, Biotherapy, and immunotherapy_Chapter 8: Standard Chemotherapy -- Chapter 9: Caring for patients during and after Immunotherapy treatment -- Chapter 10: Biotherapy treatment -- Part III: Supportive Health Care for treatment_Chapter 11: Pulmonary rehab -- Chapter 12: Physical therapy -- Chapter 13: Occupation therapy -- Chapter 14: Nutrition -- Chapter 15: Mental health treatment -- Chapter 16: Pain Management -- Chapter 17: Palliative Care -- Chapter 18: Long Term care and Survivorship -- Chapter 19: End- of-Life care -- Chapter 20: Patient perspective on mesothelioma treatment -- Part IV: Public health impact of asbestos world wide_Chapter 21: Public health impact of asbestos world wide: History of asbestos use -- Chapter 22: Public health impact of asbestos world wide: What is the current public health impact? -- Chapter 23: Nurse Educator Asbestos Related Diseases the Lung Foundation Australia -- Part V: The future of Mesothelioma Research_Chapter 24: Clinical Trials -- Chapter 25: Basic Science Research -- Chapter 26: Genetics and Genetic Counseling -- Part VI: Patient's perspective_Chapter 27: Patient involment in research -- Chapter 28: The development of mesothelioma foundations and patient support -- Chapter 29: The impact of social media mesothelioma.
520 3 _aThis book encompasses all areas for mesothelioma care, treatment, and research. Using nurses, social workers, surgeons, oncologist, radiologist and pain specialist to give the reader a comprehensive overview of mesothelioma treatment. Indeed, mesothelioma is a cancer that mainly affects the pleura and peritoneum, usually caused by exposure to asbestos. The number of individuals diagnosed with mesothelioma is increasing world-wide, particularly in developing countries where the use of asbestos remains uncontrolled. In spite of advances in chemotherapy, radiotherapy, and surgical approaches, mesothelioma remains resistant to treatment. According to the International Mesothelioma Interest group, overall survival has not improved; median survival times vary from one month to eighteen months. A small number of patients remain asymptomatic or with minimal symptoms for extended periods, and fewer live three years or more. Mesothelioma is often associated with difficult, intractable symptoms, particularly pain and difficulty breathing. Especially poor prognoses have been reported for those diagnosed with sarcomatoid rather than epithelioid histology, or with advanced disease, poor performance status, or pain and loss of appetite. Despite substantial progress of the last two decades improving the quality of life of patients with cancer, many mesothelioma patients still experience physical, psychological, social, and financial burdens. The development of multimodality treatment and mesothelioma centers has given renewed hope to patients. This book serves as a unique tool for medical professional while providing care for mesothelioma patients.
988 _aSpringer_Medicine_2019
650 7 _9670259
_aMesotelioma
700 1 _aHesdorffer, Mary.
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
700 1 _aBates-Pappas, Gleneara E.
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
776 0 8 _iPrinted edition:
_z9783319962436
776 0 8 _iPrinted edition:
_z9783319962450
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-319-96244-3
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942 _2lcc
_cLE
998 _dz
_feng
_ggw
_h0
_b09/2019
_eh
_zSI